A recent article from Cleveland.com takes a look at how drug companies may be manipulating potential patients by asking them to speak to their doctors about a particular drug. This is actually a fairly contentious issue, as drug companies formerly were not able to market directly to patients through television and magazine ads. Eventually, the U.S. Food and Drug Administration allowed direct marketing, and that is when everything changed.
Before this, there were no cartoon characters, or even a claymation lower intestine that tell us which medication can help with digestion. One of the drugs discussed in this article is Eliquis. Eliquis is member a class of drugs known as new oral anticoagulants (NOACs). This medicine is for patients who suffer from a serious medical condition known as atrial fibrillation (Afib). Continue reading